Shandong Xinhua Pharmaceutical Company Limited announced earnings results for the nine months ended September 30, 2021. For the nine months, the company announced sales was CNY 4,940.192 million compared to CNY 4,638.516 million a year ago. Operating income was CNY 344.208 million compared to CNY 335.629 million a year ago. Net income was CNY 285.336 million compared to CNY 246.066 million a year ago. Basic earnings per share from continuing operations was CNY 0.46 compared to CNY 0.4 a year ago. Diluted earnings per share from continuing operations was CNY 0.45 compared to CNY 0.4 a year ago.